3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Genitourinary
1
Breast
1
Conditions
Testicular Germ Cell Tumor
1
Sarcoma
1
Pulmonary Disease, Chronic Obstructive
1
Ovarian Neoplasms
1
Neoplasms
1
Lung Diseases, Interstitial
1
Dyspnea
1
Breast Neoplasms
1
Interventions
Bevacizumab
21
Paclitaxel
18
Carboplatin
13
pembrolizumab
11
olaparib
10
liposomal doxorubicin
10
Gemcitabine
9
Cyclophosphamide
9
Specimen Handling
8
Topotecan
7
Magnetic Resonance Spectroscopy
7
fludarabine
6
Fulvestrant
6
Taxes
5
Immunoglobulin G
5
Disulfides
5
palbociclib
4
niraparib
4
mirvetuximab soravtansine
4
Oxaliplatin
4
Nivolumab
4
Biopsy
4
trastuzumab deruxtecan
3
ipatasertib
3
cediranib
3
capivasertib
3
atezolizumab
3
aldesleukin
3
Leucovorin
3
Fluorouracil
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Hypnosis
×
30 days
×
Clear all
NCT07614620
2026-05-29
HYPNO-AJA2
Institut Bergonié
Phase NA
Not yet recruiting
70 enrolled